DYAI — Dyadic International Share News
0.000.00%
Last trade - 00:00- $15.99m
- $17.91m
- $3.09m
Brief: Epygen Biotech Reports Funding from India Government for Development of COVID-19 Vaccine
Brief: Dyadic Reports 2021 Year End Results And Recent Company Progress
Dyadic International Inc reports results for the quarter ended in December - Earnings Summary
Dyadic International Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: Dyadic International Inc Says Co And Sorrento Therapeutics Mutually Agreed To Terminate The Term Sheet
Refinitiv Newscasts - Meet TikTok's favorite Jordanian grandma
Brief: Dyadic Introduces Novel Method To Produce Synthetic Cannabinoids And Precursors Utilizing C1 Cell Line Production Platform And Patent Pending Process
Brief: Dyadic Announces A NIIMBL Coronavirus Grant Under The White House’S American Rescue Plan
U.S. STOCKS ON THE MOVE-General Motors, Freshpet, Rivian, energy stocks
U.S. STOCKS ON THE MOVE-Rivian, Darden Restaurants, General Motors, FedEx
Brief: Dyadic Announces Agreement With Janssen For Manufacture Of Therapeutic Protein Candidates Using Its C1 Platform
Dyadic up on licensing deal with Janssen Biotech
Dyadic International Inc reports results for the quarter ended in September - Earnings Summary
Brief: Dyadic Reports Third Quarter 2021 Financial Results And Highlights Recent Company Progress
Dyadic International Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Dyadic International Says Co, Sorrento Continue To Negotiate Certain Matters Relating To Certain Provisions Of License Agreement
Brief: Dyadic International Inc QTRLY Loss Per Share $0.14
Dyadic International Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-WW International, AppHarvest, CohBar